IRIS PubliCatt

Sica, Simona
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 9.755
EU - Europa 8.673
AS - Asia 3.558
OC - Oceania 167
SA - Sud America 133
AF - Africa 105
Continente sconosciuto - Info sul continente non disponibili 11
Totale 22.402
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 9.554
DE - Germania 2.278
SE - Svezia 1.632
IT - Italia 1.516
CN - Cina 1.380
SG - Singapore 966
IE - Irlanda 586
UA - Ucraina 527
FR - Francia 475
GB - Regno Unito 465
ID - Indonesia 381
IN - India 270
RU - Federazione Russa 239
FI - Finlandia 237
CA - Canada 165
ES - Italia 152
AU - Australia 145
PL - Polonia 119
TR - Turchia 107
JP - Giappone 93
NL - Olanda 84
KR - Corea 83
BR - Brasile 68
IR - Iran 61
BE - Belgio 57
HK - Hong Kong 57
CI - Costa d'Avorio 55
CZ - Repubblica Ceca 40
RO - Romania 39
CH - Svizzera 29
AR - Argentina 28
MX - Messico 26
AT - Austria 23
NZ - Nuova Zelanda 22
BG - Bulgaria 21
HU - Ungheria 21
PT - Portogallo 21
TH - Thailandia 21
EG - Egitto 20
IL - Israele 18
GR - Grecia 17
VN - Vietnam 16
NO - Norvegia 15
TW - Taiwan 15
LT - Lituania 13
PK - Pakistan 13
CL - Cile 12
CO - Colombia 12
MY - Malesia 12
SK - Slovacchia (Repubblica Slovacca) 12
DZ - Algeria 10
PH - Filippine 9
SA - Arabia Saudita 9
AE - Emirati Arabi Uniti 8
HR - Croazia 8
RS - Serbia 8
BA - Bosnia-Erzegovina 7
LB - Libano 7
ZA - Sudafrica 7
BZ - Belize 6
EU - Europa 6
A2 - ???statistics.table.value.countryCode.A2??? 5
DK - Danimarca 5
EC - Ecuador 5
NP - Nepal 5
PE - Perù 5
BY - Bielorussia 4
EE - Estonia 4
IQ - Iraq 4
MA - Marocco 4
MD - Moldavia 4
QA - Qatar 4
LI - Liechtenstein 3
LV - Lettonia 3
MK - Macedonia 3
BD - Bangladesh 2
DO - Repubblica Dominicana 2
ET - Etiopia 2
GE - Georgia 2
GH - Ghana 2
JO - Giordania 2
KE - Kenya 2
KZ - Kazakistan 2
LU - Lussemburgo 2
LY - Libia 2
SY - Repubblica araba siriana 2
UY - Uruguay 2
UZ - Uzbekistan 2
AL - Albania 1
AM - Armenia 1
AZ - Azerbaigian 1
BO - Bolivia 1
CY - Cipro 1
IS - Islanda 1
KG - Kirghizistan 1
LA - Repubblica Popolare Democratica del Laos 1
MC - Monaco 1
MM - Myanmar 1
MT - Malta 1
PA - Panama 1
Totale 22.399
Salva come PNG Salva come JPEG
Città #
Chandler 1.551
Ashburn 789
Singapore 702
Dublin 575
Jacksonville 405
San Mateo 370
Jakarta 367
Dearborn 304
Wilmington 303
Milan 297
Woodbridge 274
Ann Arbor 267
Nanjing 255
Beijing 211
Houston 208
Redwood City 199
Boston 192
Princeton 191
Moscow 187
Cattolica 174
Rome 169
Fairfield 161
Seattle 161
New York 136
Lancaster 131
Nürnberg 130
Los Angeles 125
Lawrence 118
Redmond 114
Oviedo 111
Marseille 110
Munich 110
Nanchang 110
Chicago 98
Hangzhou 88
Bremen 84
Helsinki 76
Izmir 68
Boardman 67
Toronto 67
Norwalk 62
Mountain View 58
Abidjan 55
Warsaw 55
Brussels 53
Kunming 48
Cambridge 47
Hebei 47
London 44
Shenyang 43
Florence 42
Tianjin 40
Zawidów 40
Pune 39
Zhengzhou 39
Hong Kong 38
Hefei 36
Frankfurt am Main 35
Shanghai 34
Washington 34
Busto Arsizio 33
Guangzhou 33
Changsha 32
Auburn Hills 31
Jiaxing 31
San Francisco 30
Sydney 30
Leawood 28
Phoenix 27
Brno 26
Melbourne 26
Brisbane 25
Santa Clara 25
Bologna 24
Philadelphia 24
Portland 24
Tokyo 24
Asan 23
Augusta 23
Naples 23
University Park 23
Adelaide 22
Lappeenranta 22
Amsterdam 21
Buffalo 21
Brooklyn 20
Buenos Aires 20
Rochester 19
Bangkok 17
Jinan 17
Ottawa 17
San Diego 17
São Paulo 17
Paris 16
Turin 16
Atlanta 15
Padova 15
Hanoi 14
Kansas City 14
Lanzhou 14
Totale 11.843
Salva come PNG Salva come JPEG
Nome #
VITAMIN B12 DEFICIENCY: CORRELATION BETWEEN MTHFR POLYMORPHISMS AND CLINICAL AND LABORATORY FINDINGS 2.355
HIGH-DOSE CHEMOTHERAPY WITH AUTOLOGOUS STEM CELL TRANSPLANTATION IN FIRST LINE TREATMENT FOR HIGH-RISK DIFFUSE LARGE B CELL LYMPHOMA (DLBCL) IN THE RITUXIMAB ERA: AN INTENTION TO TREAT-ANALYSIS 359
Reliability of leukostasis grading score to identify patients with high-risk hyperleukocytosis 309
Elevated lactate dehydrogenase has prognostic relevance in treatment-naïve patients affected by chronic lymphocytic leukemia with trisomy 12 286
Dasatinib first-line: Multicentric Italian experience outside clinical trials 265
Dasatinib first-line: Multicentric Italian experience outside clinical trials 263
comparison of haploidentical bone marrow versus matchet unrelated donor peripheral blood stem cell transplantation with posttransplant cyclophosphamide in patients with acute leukemia 238
Twenty years of unrestricted hematopoietic stem cell collection and storage: impact of Joint Accreditation Committee International Society for Cellular Therapy Europe standards implementation on stem cell storage policy and resource utilization 229
Salivary proteomic analysis and acute graft versus host disease after allogeneic hematopoietic stem cell transplantation 171
Management of infection in PNH patients treated with eculizumab or other complement inhibitors: Unmet clinical needs 164
Severe veno-occlusive disease after autologous peripheral blood stem cell transplantation for high-grade non-Hodgkin lymphoma: report of a successfully managed case and a literature review of veno-occlusive disease. 149
Comparison between oral and intravenous fludarabine plus cyclophosphamide regime as front-line therapy in patients affected by chronic lymphocytic leukaemia: influence of biological parameters on the clinical outcome 149
Prospective study of hepatitis B virus reactivation in patients with hematological malignancies 148
Intralesional administration of rituximab for treatment of CD20 positive orbital lymphoma: safety and efficacy evaluation 146
Correlation between paraproteinaemia and viral reactivation after allo-SCT 142
MTHFR polymorphysms in myelodysplastic syndromes and therapy-related myeloid neoplasms 141
Sorafenib for refractory FMS-like tyrosine kinase receptor-3 (FLT3/ITD+) acute myeloid leukemia after allogenic stem cell transplantation. 138
Bendamustine in combination with rituximab for elderly patients with previously untreated B-cell chronic lymphocytic leukemia: A retrospective analysis of real-life practice in Italian hematology departments 138
Characteristics and outcome of therapy-related myeloid neoplasms: Report from the italian network on secondary leukemias. 135
Peripherally inserted central catheters (PICCs) in the management of oncohematological patients submitted to autologous stem cell transplantation 134
Carbapenemase-producing Klebsiella pneumoniae and hematologic malignancies 133
Serum of healthy donors receiving granulocyte colony-stimulating factor induces T cell unresponsiveness 132
Efficacy of lenalidomide plus dexamethasone for POEMS syndrome relapsed after autologous peripheral stem-cell transplantation 129
Donor erythrocytosis induced by sorafenib treatment after allogeneic hematopoietic SCT in a patient with acute myeloid leukemia 128
Increased risk of acute myeloid leukaemia due to polymorphisms in detoxification and DNA repair enzymes. 124
The role of HLA--G 14-bp polymorphism in allo-HSCT after short-term course MTX for GvHD prophylaxis 124
Prospective evaluation of Epstein-Barr virus reactivation after stem cell transplantation: association with monoclonal gammopathy. 122
Dose-Dependent Effect of Granulocyte Transfusions in Hematological Patients with Febrile Neutropenia 122
Intralesional administration of rituximab for treatment of CD20 positive orbital lymphoma: Safety and efficacy evaluation. 120
Highly active antiretroviral therapy and allogeneic CD34(+) peripheral blood progenitor cells transplantation in an HIV/HCV coinfected patient with acute myeloid leukemia 118
Chronic lymphocytic leukemia with eyelid involvement responding to alemtuzumab. 117
Low incidence of secondary neoplasia after autotransplantation for lymphoproliferative disease: the role of pre-transplant therapy 116
Low-dose valganciclovir as preemptive therapy for cytomegalovirus infection occurring in allogeneic stem cell transplant recipients 116
Carbapenemase-producingKlebsiella pneumoniaeand Hematologic Malignancies 115
A machine-learning parsimonious multivariable predictive model of mortality risk in patients with Covid-19 115
Clinical reversible myelopathy in T-cell lymphoblastic lymphoma treated with nelarabine and radiotherapy: report of a case and review of literature of an increasing complication 111
Role of 18F-FDG PET-CT for evaluating the response to reduced-intensity conditioning allogeneic transplant in heavily pre-treated patients with chronic lymphocytic leukemia: preliminary results in nine patients. 108
in Higher-Risk Myelodysplastic Syndromes and Low Blast Count Acute Myeloid Leukemia: Results of the BMT-AZA Prospective Study 108
Dasatinib as first-line treatment for adult patients with Philadelphia chromosome-positive acute lymphoblastic leukemia 107
revalence, characteristics and management of occult hepatitis B virus infection in patients with chronic lymphocytic leukemia: a single center experience. 107
Oral fludarabine and cyclophosphamide as front-line chemotherapy in patients with chronic lymphocytic leukemia. The impact of biological parameters in the response duration 106
EXTREME THROMBOCYTOSIS IN CHRONIC MYELOID LEUKEMIA IN THE ERA OF TYROSINE KINASE INHIBITORS 105
AB0 type does not affect platelet engraftment after autologous peripheral blood stem cell transplant in a series of 249 hematologic patients 104
Influence of the JAK2 V617F mutation and inherited thrombophilia on the thrombotic risk among patients with essential thrombocythemia 104
A T cell lymphoblastic lymphoma with mucormycosis as unusual etiology of acute cerebral ischemia 104
The use of low-dose alemtuzumab in pretreated B-cell chronic lymphocytic leukemia. Leukemia. 103
Prospective evaluation of epstein-barr virus reactivation after stem cell transplantation: association with monoclonal gammopathy. 103
New and old monoclonal antibodies for the treatment of chronic lymphocytic leukemia 103
Sorafenib for refractory FMS-like tyrosine kinase receptor-3 (FLT3/ITD+) acute myeloid leukemia after allogenic stem cell transplantation 103
Hyperleukocytosis and leukostasis: management of a medical emergency 103
Role of (18)F-FDG PET-CT for evaluating the response to reduced-intensity conditioning allogeneic transplant in heavily pre-treated patients with chronic lymphocytic leukemia: preliminary results in nine patients 102
Hyperleukocytosis and leukostasis: management of a medical emergency 102
Work related acute leukemia and mucor mycosis in a boat-builder 101
Outcome of Allogeneic Hematopoietic Stem Cell Transplantation in Adult Patients with Philadelphia Positive Acute Lymphoblastic Leukemia in the Era of Tyrosine Kinase Inhibitors. A Registry-Based Study of the Italian Blood and Marrow Transplantation Society (Gitmo) 101
Role of fecal calprotectin as biomarker of gastrointestinal GVHD after allogeneic stem cell transplantation 100
H1N1 Influenza among Hematological Patients: Monocentric Influenza Cases from 2011 to 2016 100
Neurologic improvement after peripheral blood stem cell transplantation in poems 99
Characteristics and outcome of therapy-related myeloid neoplasms: Report from the Italian network on secondary leukemias 99
The role of MTHFR and RFC1 polymorphisms on toxicity and outcome of adult patients with hematological malignancies treated with high-dose methotrexate followed by leucovorin rescue 97
Prevalence, characteristics and management of occult hepatitis B virus infection in patients with chronic lymphocytic leukemia: a single center experience 95
Autologus stem cell transplantation as bridging rherapy followed by CD19 Car-T cells in relapsed refractory large B cell lymphoma 95
Reduced-intensity conditioning allogeneic transplant in heavily pre-treated chronic lymphocytic leukaemia patients: a single centre experience 92
Invasive fungal infections in chronic lymphoproliferative disorders: a monocentric retrospective study 92
Twenty years of unrestricted hematopoietic stem cell collection and storage: impact of Joint Accreditation Committee International Society for Cellular Therapy Europe standards implementation on stem cell storage policy and resource utilization 91
Invasive fungal infections in chronic lymphoproliferative disorders: A monocentric retrospective study 91
MTHFR polymorphisms involved in vitamin B12 deficiency associated with atrophic gastritis 90
Clonal evolution in therapy-related neoplasms 90
Role of flow-cytometric immunophenotyping in prediction of BCR/ABL1 gene rearrangement in adult B-cell acute lymphoblastic leukemia 89
Non-tunnelled central venous catheters in adult stem cell transplantation recipients: an effective option 87
Peripherally inserted central catheters (PICCs) in the management of oncohematological patients submitted to autologous stem cell transplantation 87
Efficacy of Ceftazidime-avibactam Salvage Therapy in Patients with Infections Caused by KPC-producing Klebsiella pneumoniae 87
Treatment of primary plasma cell leukemia with high doses of cyclophosphamide, bortezomib, and dexamethasone followed by double autologous HSCT 86
Long-term follow up of frontline therapy with fludarabine and cyclophosphamide in chronic lymphocytic leukemia: impact of biological parameters on clinical outcome 85
Bloodstream infections caused by Klebsiella pneumoniae in onco-hematological patients: clinical impact of carbapenem resistance in a multicentre prospective survey 85
Chlorambucil plus Rituximab as Front-Line Therapy in Elderly/Unfit Patients Affected by B-Cell Chronic Lymphocytic Leukemia: Results of a Single-Centre Experience 84
High-dose glucocorticoids plus Ofatumumab in fludarabine/alemtuzumab-resistant B-cell chronic lymphocytic leukemia 81
Molecular characterization of adenovirus from clinical samples through analysis of the hexon and fiber genes 80
Reduced-intensity conditioning allogeneic transplant in heavily pre-treated chronic lymphocytic leukaemia patients: a single centre experience 80
Randomized phase III trial of retinoic acid and arsenic trioxide versus retinoic acid and chemotherapy in patients with acute promyelocytic leukemia: health-related quality-of-life outcomes 80
Infections by carbapenem-resistant Klebsiella pneumoniae in SCT recipients: a nationwide retrospective survey from Italy 79
Invasive fungal infections in chronic lymphoproliferative disorders: a monocentric retrospective study 79
SARS-COV-2 vaccination in patients with paroxysmal nocturnal hemoglobinuria an italian multicenter survey 78
Autologous stem cell transplantation as bridging therapy followed by CD19 CAR-T cells in relapsed-refractory large B cell lymphoma. 78
Drug resistance and BCR-ABL kinase domain mutations in philadelphia chromosome-positive acute lymphoblastic leukemia from the imatinib to the second-generation tyrosine kinase inhibitor era: The main changes are in the type of mutations, but not in the frequency of mutation involvement 77
Bloodstream infections caused by Klebsiella pneumoniae in onco-hematological patients: clinical impact of carbapenem resistance in a multicentre prospective survey 77
Fecal but not serum calprotectin is a potential marker of GVHD after stem cell transplantation. 77
Blinatumomab as a successful and safe therapyin Down syndrome patients with relapsed / refractory b-precursor acute lymphoblastic leukemia: Case report and literature review 77
Molecular characterization of adenovirus from clinical samples through analysis of the hexon and fiber genes 75
UGT1A1 Polymorphism and Mortality Outcome after Allogeneic Stem Cell Transplantation with Busulfan Based Regimen 75
Peripheral Blood Hemopoietic Stem Cell Mobilization Regimens in POEMS Syndrome: A Retrospective Study at 2 Hematologic Italian Centers 74
Eltrombopag for the treatment of poor graft function following allogenic stem cell transplant: a retrospective multicenter study 74
Alternative donor transplants for severe aplastic anemia: current experience 73
Changes in protein serum levels during stem cell transplantation 73
Lymph node blast crisis in chronic myeloid leukemia mimicking T-immunoblastic lymphoma. 72
Two types of BCR interactions are positively selected during leukemia development in the Eμ-TCL1 transgenic mouse model of CLL 72
Reduction of hospitalization and transfusion support in patients with acute promyelocytic leukemia treated with arsenic trioxide plus all-trans retinoic acid compared to chemotherapy plus all-trans retinoic acid 72
Imatinib and polypharmacy in very old patients with chronic myeloid leukemia: Effects on response rate, toxicity and outcome 71
Allogeneic Hemopoietic Stem Cell Transplants in Patients with Acute Myeloid Leukemia (AML) Prepared with Busulfan and Fludarabine (BUFLU) or Thiotepa, Busulfan, and Fludarabine (TBF): A Retrospective Study 71
Age influences initial dose and compliance to imatinib in chronic myeloid leukemia elderly patients but concomitant comorbidities appear to influence overall and event-free survival 69
Extracorporeal Photopheresis for Treatment of Acute and Chronic Graft Versus Host Disease: An Italian Multicentric Retrospective Analysis on 94 Patients on Behalf of the Gruppo Italiano Trapianto di Midollo Osseo 69
Totale 13.679
Salva come PNG Salva come JPEG
Categoria #
all - tutte 106.735
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 106.735
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/20201.167 0 0 0 0 0 0 230 131 147 209 274 176
2020/20212.211 435 239 76 125 184 109 139 62 292 90 386 74
2021/20222.639 249 128 79 139 163 78 66 392 141 179 510 515
2022/20235.141 753 662 414 713 371 621 258 338 570 170 180 91
2023/20243.843 121 829 176 190 211 540 221 153 165 249 467 521
2024/20252.745 419 337 612 532 570 274 1 0 0 0 0 0
Totale 22.915